Das sympatho-adrenerge System bei Herzinsuffizienz

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 5, 1996, Pages 141-145

  Ungerer, M ^a,b   Hartmann, F ^a,b   Richardt, G ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR; BISOPROLOL; CARVEDILOL; DOBUTAMINE; METOPROLOL; NORADRENALIN;

ADRENERGIC SYSTEM; DRUG MECHANISM; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; REVIEW; SYNAPSE;

HEART FAILURE, CONGESTIVE; HUMANS; RECEPTORS, ADRENERGIC; RECEPTORS, PRESYNAPTIC; SYMPATHETIC NERVOUS SYSTEM;

EID: 0030026062     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1042986     Document Type: Article

References (60)

1. Adamopoulos, S., M. Piepoli, F. Qiang, E. Pissimissis, M. Davies, L. Bernardi, C. Forfar, P. Sleight, A. Coats: Effects of pulsed β-stimulant therapy on β-adrenoceptors and chronotropic responsiveness in chronic heart failure. Lancet 345 (1995), 344-348.
2. Anderson, F. L, J. D. Port, B. B. Reid, P. Larabee, C. Hanson, M. R. Bristow: Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy: Correlation with β-adrenergic receptor downregulation. Circulation 85 (1992), 46-53.
3. Beau, S. L., J. E. Saffitz: Transmural heterogeneity of norepinephrine uptake in failing human hearts. J. Amer. Coll. Cardiol. 23 (1994), 579-585.
4. Böhm, M., D. Beuckelmann, L. Brown, G. Feiler, B. Lorenz, M. Näbauer, B. Kemkes, E. Erdmann: Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated diseased human myocardium. Europ. Heart J. 9 (1988), 844-852.
5. Böhm, M., F. Diet, C. Feiler, B. Kemkes, E. Erdmann: α-adrenoceptors and α-adrenoceptor mediated positive inotropic effects in failing human myocardium. J. cardiovasc. Pharmacol. 12 (1988), 357-364.
6. 1α in human hearts with dilated but not ischemic cardiomyopathy. Circulation 82 (1990), 1249.
7. Böhm, M., K. LaRosee, R. H. G. Schwinger, E. Erdmann: Evidence for reduction of norepinephrine uptake sites in the failing human heart. J. Amer. Coll. Cardiol. 25 (1995), 146-153.
8. 2-adrenoceptor subpopulation. J. cardiovasc. Pharmacol. 14 (1989), 549-559.
9. Böhm, M., M. Ungerer, E. Erdmann: Beta adrenoceptors and m-cholinoceptors in myocardium of hearts with coronary artery disease or idiopathic dilated cardiomyopathy removed at cardiac transplantation. Amer. J. Cardiol. 66 (1990), 880-882.
10. Bristow, M. R., R. Ginsburg, W. Minobe, R. S. Cubiciotti, W. S. Sageman, K. Lurie, M. E. Billingham, D. E. Harrison, E. B. Stinson: Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. New Engl. J. Med. 307 (1982), 205-211.
11. Bristow, M. R., R. Ginsburg, A. Strosberg, W. Montgomery, W. Minobe: Pharmacology and inotropic potential of forskolin in the human heart. J. clin. Invest. 74 (1984), 212-223.
12. 1-receptor downregulation in heart failure. Circulat. Res. 559 (1986), 297-309.
13. 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Molec. Pharmacol. 35 (1989), 295-303.
14. 2-adrenoceptors in the human heart. Properties, function, and alterations in chronic heart failure. Pharmacol. Rev. 43 (1991), 203-242.
15. Brown, L. A., S. E. Harding: The effects of pertussis toxin on β-adrenoceptor responses in isolated cardiac myocytes from noradrenaline-treated guinea pigs and patients with cardiac failure. Brit. J. Pharmacol. 106 (1992), 115-122.
16. Chidsey, C. A., E. Braunwald, A. G. Morrow: Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Amer. J. Med. 39 (1965), 442-451.
17. Chidsey, C. A., D. C. Harrison, E. Braunwald: Augmentation of plasma norepinephrine response to exercise in patients with congestive heart failure. New Engl. J. Med. 267 (1962), 650-657.
18. CIBIS Investigators and Committees: A randomized trial of β-blockade in heart failure. The cardiac insufficiency bisoprolol study. Circulation 90 (1994), 1765-1773.
19. Cleland, J. G. F., H. J. Dargie: Arrhythmias, catecholamines and electrolytes. Amer. J. Cardiol. 62 (1988), 55-59.
20. Cohn, J. N., T. B. Levine, M. T. Olivari, V. Garberg, D. Lura, G. S. Francis, A. B. Simon: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New Engl. J. Med. 311 (1984), 819-823.
21. Creager, A. M.: Baroreceptor reflex function in congestive heart failure. Amer. J. Cardiol. 69 (1992), 10-15.
22. Davis, D., R. Baily, R. Zelis: Abnormalities in systemic norepinephrine kinetics in human congestive heart failure. Amer. J. Physiol. 254 (1987), 760-766.
23. 1α-2 in human end-stage heart failure. Circulat. Res. 70 (1992), 688-696.
24. Esler, M., G. Jennings, P. Korner, J. Willet, F. Dudley, G. Hasking, W. Anderson, G. Lambert: Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11 (1988), 3-20.
25. Feldman, A. M., A. E. Cates, W. B. Veazey, R. E. Hershberger, M. R. Bristow, K. L. Baughman, W. A. Baumgartner, C. Van Dop: Increase in the 40000-mol wt pertussis toxin substrate (G-protein) in the failing human heart. J. clin. Invest. 82 (1988), 189-197.
26. Fisher, M. L., S. S. Gottlieb, G. D. Plotnick, N. L. Greenberg, R. D. Patten, S. K. Bennett, B. P. Hamilton: Beneficial effects of metoprolol in heart failure associated with coronary artery disease. A randomized trial. J. Amer. Coll. Cardiol. 23 (1994), 943-950.
27. Francis, G. S., C. Benedict, D. E. Johnstone, P. C. Kirlin, J. Nicklas, C. Liang, S. H. Kubo, E. Rudin-Toretski, S. Yusef: Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 82 (1990), 1724-1730.
28. Fuller, S. J., C. J. Aitanaki, P. H. Sudgen: Effects of catecholamines on protein synthesis in cardiac myocytes and perfused hearts isolated from adult rats. Biochem. J. 266 (1990), 727-736.
29. Goldstein, D. S.: Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology. Amer. J. Cardiol. 48 (1981), 1147-1154.
30. Hartmann, F., S. Ziegler, P. Watzlowik, M. Hadamitzki, G. Richardt, M. Schwaiger: Evidence of regional myocardial sympathetic denervation in dilated cardiomyopathy. Europ. Heart J. 16, Suppl. (1995), 164.
31. Heilbrunn, S. M., P. Shah, M. R. Bristow, H. A. Valantine, R. Ginsburg, M. B. Fowler: Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 79 (1989), 483-490.
32. Hirsch, A.T., C. E. Talsness, H. Schunkert, M. Paul, V.J. Dzau: Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circulat. Res. 69 (1991), 475-482.
33. Katz, A. M.: Cardiomyopathy of overload. New Engl. J. Med. 322 (1990), 100-110.
34. Koch, W. J., H. A. Rockman, P. Samama, R. A. Hamilton, R. A. Bond, C. Milano, R. J. Lefkowitz: Cardiac function of mice overpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 268 (1995), 1350-1353.
35. Leimbach, W. N., B. G. Wallin, R. G. Victor, P. E. Aylward, G. Sundlöf, L. Mark: Direct evidence from intraneuronal recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73 (1986), 913-919.
36. Levine, T. B., G. S. Francis, S. R. Goldsmith, A. B. Simon, J. N. Cohn: Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Amer. J. Cardiol. 49 (1982), 483-487.
37. Ling, C. S., T. H. M. Fan, J. T. Sullebarger, S. Sakamoto: Decreased adrenergic neuronal uptake activity in experimental right heart failure. J. clin. Invest. 84 (1989), 1267-1275.
38. 11C CGP 12 177 to assess β-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 87 (1993), 1169-1178.
39. Merlet, P., J. L. Dubois-Rande, S. Adnot, M. H. Bourguignon, C. Benvenuti, D. Loisance, H. Valette, A. Castaigne, A. Syrota: Myocardial β-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J. cardiovasc. Pharmacol. 19 (1992), 10-16.
40. Merlet, P., H. Valette, R. J. Dubois-Randé, D. Moyse, D. Duboc, P. Dove, M. H. Bourguignon, C. Benvenuti, A. M. Duval, D. Agostini, D. Loisance, A. Castaigne, A. Syrota: Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J. nucl. Med. 33 (1992), 471-477.
41. 2-adrenergic receptor. Science 264 (1994), 582-585.
42. Morgan, H. E., K. M. Baker: Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation 83 (1991), 13-25.
43. Olsen, S. L., E. M. Gilbert, D. G. Renlund, D. O. Taylor, F. D. Yanowitz, M. R. Bristow: Carvedilol improves left ventricular function and symptoms in chronic heart failure. A double-blind randomized study. J. Amer. Coll. Cardiol. 25 (1995), 1225-1231.
44. Packer, M.: Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77 (1988), 721-730.
45. Pamley, W. W.: Factors causing arrhythmias in chronic congestive heart failure. Amer. Heart J. 5 (1987), 1267-1272.
46. 45a Ping, P. P., R. Gelzer-Bell, D. A. Roth, D. Kiel, P. A. Insel, H. K. Hammond: Reduced β-adrenergic receptor activation decreases G-protein expression and β-adrenergic receptor kinase activity in porcine heart. J. clin. Invest. 95 (1995), 1271-1280.
47. De Quatro, V., T. Nagatsu, A. Mendez, J. Verska: Determinants of cardiac norepinephrine depletion in human congestive heart failure. Cardiovasc. Res. 7 (1973), 344-350.
48. Richardt, G., F. Mayer, A. Schömig: Role of angiotensin and sodium intake in cardiac noradrenaline release. Naunyn-Schmiedeberg's Arch. Pharmacol. 344 (1991), 297-301.
49. Rose, C. P., J. H. Burgess, D. Cousineau: Reduced aortocoronary sinus extraction of epinephrine in patients with left ventricular failure secondary to longterm chronic pressure and volume overload. Circulation 68 (1983), 241-244.
50. Rose, C. P., J. H. Burgess, D. Cousineau: Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload. J. clin. Invest. 76 (1985), 1740-1747.
51. sα, in failing human myocardium. J. molec. cell. Cardiol. 22 (1990), 73-82.
52. 123I]metaiodobenzylguanidine scintigraphy. Circulation 89 (1994), 2843-2851.
53. Spann, J. F., C. A. Chidsey, P. E. Pool, E. Braunwald: Mechanism of norepinephrine depletion in experimental heart failure produced by aortic constriction in the guinea pig. Circulat. Res. 17 (1965), 312-321.
54. Swedberg, K., A. Hjalmarson, S. Holmberg: Effects of work and acute betareceptor blockade on myocardial noradrenaline release in congestive heart failure. Clin. Cardiol. 2 (1979), 424-430.
55. Swedberg, K., A. Hjalmarson, F. Waagstein, I. Wallentin: Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet 1979/I, 1374-1376.
56. Thomas, J. A., B. H. Marks: Plasma norepinephrine in congestive heart failure. Amer. J. Cardiol. 41 (1987), 233-243.
57. 1-adrenergic receptors in the failing human heart. Circulation 87 (1993), 454-463.
58. Ungerer, M., G. Parruti, M. Böhm, M. Puzicha, A. DeBlasi, E. Erdmann, M. J. Lohse: Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart. Circulat. Res. 74 (1994), 206-213.
59. Urata, H., B. Healy, R. W. Steward, F. M. Bumpus, A. Husain: Angiotensin II-forming pathways in normal and failing human hearts. Circulat. Res. 66 (1990), 883-890.
60. Waagstein, F., A. Hjalmarson, K. Swedberg, I. Wallentin: Beta-blockers in dilated cardiomyopathy. They work. Europ. Heart J. 4, Suppl. A (1983), 173-177.